I don't want to rain on anyone's parade here but am I missing...

I don't want to rain on anyone's parade here but am I missing something, where is the clinical data from the late SEP ASX release.

How does the recent ASX release support an increase in Market Cap from $9M to $87M ?  Oh, I forgot right there are 78M NOV 6c options coming up for expiry - LOL

BIT directors need to be very careful here IMO and should be consulting GSW's new governance manual regarding ASX releases - LOL again !

I wouldn't be surprised to see a clarification request from ASX here in the short term.

Watch out below !

PS. I would be happy to buy BIT at 14c if the data showed clinical benefit and the PII trial reached its end-points but this could only be judged AFTER one reviewed the data

As long as everyone realizes that they're playing red or black here all good !  ATB